Opening book details…
About this book
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2 by Michael G. Yang, Zili Xiao, Rulin Zhao, Andrew J. Tebben, Bei Wang, Robert J. Cherney, Douglas G. Batt, Gregory D. Brown, Mary Ellen Cvijic, John V. Duncia, Michael A. Gallela, Daniel S. Gardner, Purnima Khandelwal, Mary F. Malley, Jian Pang, Anne V.... is a book available to read on EtoBox.
- Author
- Michael G. Yang, Zili Xiao, Rulin Zhao, Andrew J. Tebben, Bei Wang, Robert J. Cherney, Douglas G. Batt, Gregory D. Brown, Mary Ellen Cvijic, John V. Duncia, Michael A. Gallela, Daniel S. Gardner, Purnima Khandelwal, Mary F. Malley, Jian Pang, Anne V....
- Published
- 2021
- Language
- EN
More by Michael G. Yang, Zili Xiao, Rulin Zhao, Andrew J. Tebben, Bei Wang, Robert J. Cherney, Douglas G. Batt, Gregory D. Brown, Mary Ellen Cvijic, John V. Duncia, Michael A. Gallela, Daniel S. Gardner, Purnima Khandelwal, Mary F. Malley, Jian Pang, Anne V....
Similar books
- Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors — Donghui Qin, Xiaojuan Lin, Zhi Liu, Yan Chen, Zhiliu Zhang, Chengde Wu, Linlin Liu, Yan Pan, Sylvie Laquerre, John Emery, Jeff Fergusson, Kimberly Roland, Rick Keenan, Allen Oliff, Sanjay Kumar, Mui Cheung & Dai-Shi Su (2021)
- Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist — Matthew Spock, Trever R. Carter, Katrina A. Bollinger, Changho Han, Logan A. Baker, Alice L. Rodriguez, Li Peng, Jonathan W. Dickerson, Aidong Qi, Jerri M. Rook, Jordan C. O’Neill, Katherine J. Watson, Sichen Chang, Thomas M. Bridges, Julie L. Engers,... (2021)
- Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10) — Makoto Fushimi, Hannes Buck, Melanie Balbach, Anna Gorovyy, Jacob Ferreira, Thomas Rossetti, Navpreet Kaur, Lonny R. Levin, Jochen Buck, Jonathan Quast, Joop van den Heuvel, Clemens Steegborn, Efrat Finkin-Groner, Stacia Kargman, Mayako Michino,... (2021)
- Novel Potent Selective Orally Active S1P5 Receptor Antagonists — Bin Ma, Kevin M. Guckian, Xiao-gao Liu, Chunhua Yang, Bing Li, Robert Scannevin, Michaël Mingueneau, Annabelle Drouillard & Thierry Walzer (2021)
- Discovery of 1,5-Dihydro-4H-imidazol-4-one Derivatives as Potent, Selective Antagonists of CXC Chemokine Receptor 2 — Jinxin Che, Zhilong Wang, Zheyuan Shen, Weihao Zhuang, Huazhou Ying, Yongzhou Hu, Youhong Hu, Xin Xie & Xiaowu Dong (2021)
- Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2 — Minh H. Nguyen, Onur Atasoylu, Liangxing Wu, Kanishk Kapilashrami, Michelle Pusey, Karen Gallagher, Cheng-Tsung Lai, Peng Zhao, Joseph Barbosa, Kai Liu, Chunhong He, Colin Zhang, Evan D. Styduhar, Michael R. Witten, Yaoyu Chen, Luping Lin, Yan-ou Yang,... (2022)